About this document This document lists and briefly describes the following areas for the releases of the ‘European database of suspected adverse drug reaction reports’ website. •
What's New: The enhancements and other changes released (new feature).
•
Known Issues: The issues that exist (open issue).
•
Fixed Issues: The issues that are fixed (fixed issue).
•
Points to Note: The important aspects to keep in mind (point to note).
Release date: 19 December 2017 Known Issues: Id
Description
Proposed workaround
Status
1
In the web report, the “Number of
The display will be updated to
Open
individual cases identified in
provide the number of cases
EudraVigilance for {product/substance
received up to, and including, the
name} is {number of cases}”
exact date (format DD MMM
currently provides the number of
YYYY).
cases received up to, and including, the previous month. 2
The access to the ‘ICSR Form’ from
The public view of ICSR forms will
the ‘Line Listing’ tab of the web report
be enabled in due course.
Open
is not yet enabled.
‘European database of suspected adverse drug reaction reports’ website (www.adrreports.eu): Release Notes v.1.0 EMA/833629/2017
European database of suspected adverse drug reaction reports ...
European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged. 19 December 2017. EMA/833629/2017. Business Data and Analytics Department. European database of suspected adverse drug reaction reports' website (www.adrreports.eu): Release notes v.1.0 ...
This paper describes the end-to-end sys- tem developed by the University of Texas. Health Science Center at Houston, Center for. Computational. Biomedicine. (UTHeath-CCB) team for the 2017 TAC track on âAdverse Drug Reaction Extrac- tion from Drug
Dec 11, 2013 - system organ class (SOC), defined by the Medical dictionary for regulatory activities ... Data representation. Each drug is represented by its chemical and biological proper- ties and is associated with a binary side effect profile, y,
9 Nov 2017 - This question and answer document on adverse event reporting was originally developed following the. Committee for Medicinal Products for Veterinary Use Pharmacovigilance Working Party (PhVWP-V) interested parties meeting on implementati
Email: tpshio@kyorinâu.ac.jp. Received 2 November .... nally return to normal on full recovery. Another .... strong positive after recovery (Manuscript in prepara-.
May 19, 2016 - 10 reports (peer-reviewed literature, internet and social. 11 media). 12. Table of ... 2.3 MAH hosted websites and social media accounts .
Dec 2, 2014 - Since then, the Australian, State and territory governments have invested $281 million towards eradicating them from southeast Queensland.
Application of MID3 to Paediatrics â Lutz Harnisch. ⢠Paediatric MID3 ... Discovery, Development and Life Cycle Management. âWhatâ MID3 .... Access to curated.
DITOP: drug-induced toxicity related protein database. Jing-Xian ... such a database that is intending to provide comprehensive ... and 418 distinct toxicity terms.
Dec 3, 2017 - Table 2. Monohalogenation of different alkynes with TXCA. R. OAc. R'. X. R. R'. 0.34 eq. TXCA. HOAc:Ac2O (1:1), r.t. ..... Spectral characterization of the products is available in the Supplementary File. References. 1. Mendonça, G. F.
